4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0001062993-23-013639
Options or other derivatives
- Executive Director acquired 153,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Boston Megan Executive Director | 2023-06-13 | Grant or award · Options (right to buy) | +153,000 | 153,000 | D | ||
Loading xslF345X04/form4.xml…